Takeda Pharmaceutical Company Limited (TAK)

Takeda Pharmaceutical Revenue

Takeda Pharmaceutical had revenue of 1.14T JPY in the quarter ending December 31, 2024, with 2.96% growth. This brings the company's revenue in the last twelve months to 4.58T, up 9.83% year-over-year. In the fiscal year ending March 31, 2024, Takeda Pharmaceutical had annual revenue of 4.26T with 5.87% growth.

• Revenue (ttm): 4,579.02B JPY
• Revenue Growth: +9.83%
• P/S Ratio: 1.54
• Revenue / Employee: 92,916,560 JPY
• Employees: 49,281
• Market Cap: 44.74B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	4,263.76B	236.28B	5.87%
Mar 31, 2023	4,027.48B	458.47B	12.85%
Mar 31, 2022	3,569.01B	371.19B	11.61%
Mar 31, 2021	3,197.81B	-93.38B	-2.84%
Mar 31, 2020	3,291.19B	1,193.96B	56.93%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.